6.74

2.32% -0.16

Pre-market: 6.75 0.010 +0.15%

Scilex Holding Company (SCLX)

Overview News Price History Option Chain Financials Why SCLX Down? Discussions Forecast

Scilex Holding Company stock is traded at $6.74, with a volume of 17,592. It is down -2.32% in the last 24 hours and down -28.60% over the past month. Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Previous Close:

$6.90

Open:

$6.8

24h Volume:

17,592

Relative Volume:

0.14

Market Cap:

$47.40M

Revenue:

$33.86M

Net Income/Loss:

$-437.38M

P/E Ratio:

-0.1661

EPS:

-40.5773

Net Cash Flow:

$-42.07M

1W Performance:

-2.88%

1M Performance:

-28.60%

6M Performance:

-18.89%

1Y Performance:

-67.90%

1-Day Range:

$6.67

$6.94

1-Week Range:

$6.5401

$7.24

52-Week Range:

$4.20

$34.27

Scilex Holding Company Stock (SCLX) Company Profile

Name

Scilex Holding Company

Sector

Healthcare (1075)

Industry

Drug Manufacturers - General (20)

Phone

(650) 516-4310

Address

960 SAN ANTONIO ROAD, PALO ALTO

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

SCLX's Discussions on Twitter

Compare SCLX vs LLY, JNJ, ABBV, MRK, NVS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SCLX Scilex Holding Company	6.74	48.53M	33.86M	-437.38M	-42.07M	-40.58
LLY Lilly Eli Co	1,209.00	1.09T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	262.08	628.65B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	250.82	439.59B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	135.55	327.94B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	151.72	289.52B	54.66B	13.58B	16.05B	7.0171

Scilex Holding Company Stock (SCLX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-27-25	Initiated	D. Boral Capital	Buy
Oct-16-24	Initiated	Alliance Global Partners	Buy
Jun-13-24	Initiated	Rodman & Renshaw	Buy
Oct-16-23	Initiated	B. Riley Securities	Buy
Oct-13-23	Initiated	B. Riley Securities	Buy
Oct-09-23	Initiated	H.C. Wainwright	Buy

View All

Scilex Holding Company Stock (SCLX) Latest News

Aug 13, 2026

Scilex Establishes $20 Million Credit Facility for Vivasor - The Globe and Mail

Aug 13, 2026

Aug 12, 2026

Scilex Holding establishes $20 million revolving credit line for Vivasor - Investing.com

Aug 12, 2026

Form 8K Scilex Holding Co For: 12 August By Investing.com - Investing.com Canada

Aug 12, 2026

Scilex Holding CoEnters Promissory Note With Vivasor For Revolving Credit Up To $20 Million, On Aug 8 - TradingView

Aug 12, 2026

Scilex Holding establishes $20 million revolving credit line for Vivasor By Investing.com - Investing.com Canada

Aug 12, 2026

Scilex Establishes Uncommitted $20 Million 10-Year Revolving Line of Credit for Vivasor - TradingView

Aug 12, 2026

Aug 07, 2026

Scilex Holding Co (SCLX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 07, 2026

Aug 06, 2026

Scilex Holding Company Revenue Breakdown – BOATS:SCLXW - TradingView

Aug 06, 2026

Aug 03, 2026

Scilex Holding (SCLX) Slips 1.58% to $6.56 as Key Support at $6.23 Moves into FocusTRIN Signal - dars.gov.et

Aug 03, 2026

Aug 01, 2026

Scilex (NASDAQ:SCLX) Trading 0.9% HigherShould You Buy? - MarketBeat

Aug 01, 2026

Jul 31, 2026

Scilex Holding Company Revenue Breakdown – NASDAQ:SCLX - TradingView

Jul 31, 2026

Scilex Holding (SCLX) Edges Lower to $6.55 as Traders Eye Key Support at $6.22Sentiment Extreme - dars.gov.et

Jul 31, 2026

Jul 28, 2026

SCLX|Scilex Holding Co|Price:7.100|Chg%:+0.260 - TradingKey

Jul 28, 2026

Jul 27, 2026

Scilex Holding Co (SCLX) Institutional Confidence - TradingKey

Jul 27, 2026

Scilex Holding Co (SCLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026

Scilex Holding Co (SCLX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

SCLX|Scilex Holding Co|Price:6.870|Chg%:+0.030 - TradingKey

Jul 27, 2026

SCLX|Scilex Holding Co|Price:6.610|Chg%:-0.055 - TradingKey

Jul 27, 2026

Scilex Holding Co (SCLX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 27, 2026

Jul 26, 2026

TradingKey - TradingKey

Jul 26, 2026

Scilex Holding Co (SCLX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 26, 2026

Scilex Holding Co (SCLX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 26, 2026

Scilex Holding (SCLX) Declines Sharply as Selling Pressure MountsVolume Profile - dars.gov.et

Jul 25, 2026

Jul 24, 2026

Scilex Holding (SCLX) Dips 3.9% as Key Support Levels Come into FocusSmart Money Flow Stocks - dars.gov.et

Jul 24, 2026

Jul 23, 2026

Scilex Announces Strategic Sale of Vivasor Preferred Shares - The Globe and Mail

Jul 23, 2026

Scilex Holding Company Enters Material Definitive Agreement – SEC Filing and Entity Information Details - Minichart

Jul 23, 2026

Jul 22, 2026

Scilex Sells Vivasor Preferred Shares Back for $12.0 Million, Paid in Tranches Through 2027 - TradingView

Jul 22, 2026

Jul 20, 2026

Scilex Holding (SCLX) Declines 5.33% as Shares Test Key Support Near $7.59High Conviction Picks - dars.gov.et

Jul 20, 2026

Jul 17, 2026